Weikang Pharmaceutical (300878.SZ): Yellow armor soft liver granules start clinical phase III trial.

Chinaventure Financial APP News, Weikang Pharmaceutical Co., Ltd. (300878.SZ) announced that the company and Yingke Rui (Zhuhai Jinwan) Pharmaceutical Co., Ltd. jointly applied, with the leading unit being the affiliated Shuguang Hospital of Shanghai University of Traditional Chinese Medicine and the participating Anhui Medical University First Affiliated Hospital, Chongqing University Affiliated Three Gorges Hospital, Chongqing Medical University Affiliated First Hospital and other 19 clinical trial centers held a project initiation meeting on conducting a "randomized, double-blind, multicenter, placebo-controlled phase III clinical trial to evaluate the effectiveness and safety of Huangjia Ruan Gan Granules in the treatment of chronic hepatitis B liver fibrosis (liver depression, spleen deficiency, blood stasis, and collaterals obstruction) ".